A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)

W. M. Carroll, T. Saida, H. J. Kim, J. Kira, A. G. Kermode, C. P. Tsai, K. Fujihara, S. Kusunoki, M. Tanaka, K. K. Kim, D. Bates

研究成果: ジャーナルへの寄稿評論記事

8 引用 (Scopus)

抜粋

Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes. The purpose of this report is to provide guidance to facilitate early treatment decisions for patients with inflammatory demyelinating disease, before definitive diagnosis. Neurology experts reviewed the existing literature and clinical evidence. A treatment decision pathway was developed, defining patients for whom first-line MS disease-modifying therapies (a) are unlikely to be effective, (b) may be effective but require careful monitoring and (c) are likely to provide benefit. This algorithm seeks to ensure that patients, particularly those in Asia, receive appropriate treatment early in inflammatory demyelinating disease.

元の言語英語
ページ(範囲)1371-1380
ページ数10
ジャーナルMultiple Sclerosis Journal
19
発行部数10
DOI
出版物ステータス出版済み - 9 2013

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

フィンガープリント A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Carroll, W. M., Saida, T., Kim, H. J., Kira, J., Kermode, A. G., Tsai, C. P., Fujihara, K., Kusunoki, S., Tanaka, M., Kim, K. K., & Bates, D. (2013). A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica). Multiple Sclerosis Journal, 19(10), 1371-1380. https://doi.org/10.1177/1352458512471092